Cargando…
Where We Stand With Precision Therapeutics in Myeloma: Prosperity, Promises, and Pipedreams
Multiple myeloma remains an incurable disease despite numerous novel agents being approved in the last decade. Furthermore, disease behavior and susceptibility to current treatments often vary drastically from patient to patient. To date there are no approved therapies in myeloma that are targeted t...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8811139/ https://www.ncbi.nlm.nih.gov/pubmed/35127532 http://dx.doi.org/10.3389/fonc.2021.819127 |